Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Mesenchymal Precursor Cells in Diabetic Nephropathy

This study has been completed.
Information provided by (Responsible Party):
Mesoblast, Ltd. Identifier:
First received: April 23, 2013
Last updated: October 12, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)